Pilot Study to Evaluate Efficacy of Botanical Extracts as Protein Amplifier for Skeletal Muscle Strength & Growth.

Muscle Strength Clinical Trial

Official title:

A Randomized, Placebo-controlled, Blinded, Pilot Study to Evaluate Efficacy of Botanical Extracts as Protein Amplifier for Skeletal Muscle Strength & Growth.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04949789
• Other study ID #: EB/200301/POLY/SMS
• Status: Completed
• Phase: N/A
• Start date: June 17, 2021
• Est. completion date: November 17, 2021

Study information

• Verified date: October 2021
• Source: Vedic Lifesciences Pvt. Ltd.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Sponsor proposes ingredients that when added to daily whey supplementation, can lead to increased muscle strength, improves sleep quality and reduction in fatigue level.

Description:

The present study is a randomized, blinded, placebo-controlled, pilot study. Approximately 40 males aged between ≥ 20 and ≤ 35 years, will be screened. Each trial arm will have at least 5 completed after accounting for dropout/withdrawal rate of 20%. The treatment duration for all the study participants will be 28 to 56 days (Day 56 is only applicable for participants with less than 10% increase in weight leg pressed for 1 RM on Day 28. All participants in arm 1 of study will have their end of study visit on Day 28).Sponsor proposes ingredients that when added to daily whey supplementation, can lead to increased muscle strength, improves sleep quality and reduction in fatigue level.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 28
• Est. completion date: November 17, 2021
• Est. primary completion date: November 17, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 20 Years to 35 Years

Eligibility

Inclusion Criteria:

1. Males aged 20 - 35 years with active lifestyle moderate physical activity level as per International Physical Activity Questionnaire.

2. Recreationally active but not participating in resistance type training on regular basis.

3. Body mass index (BMI) 22 - 29.9 kg/ m2

4. Participants with an Insomnia Severity Index score =7 and =14

5. Ready to refrain from caffeinated products and intense strength/ endurance exercise for 24 hrs. prior to the exercise lab visit.

6. Fasting Glucose = 110 mg/ dl

7. Systolic Blood Pressure = 129 mm Hg and Diastolic Blood Pressure = 89 mm Hg

8. TSH (thyroid stimulating hormone) =0.4 and = 4.9 mIU/L

Exclusion Criteria:

1. Engaged in structured weight training during the previous 12 months prior to screening.

2. Presence of chronic disease.

3. Changes in body weight more than 4.5 kg (10 pounds) in the past three months.

4. Participants with uncontrolled hypertension.

5. Participants who are diagnosed with Type II Diabetes Mellitus.

6. History or presence of clinically significant renal, hepatic, endocrine, biliary, gastrointestinal, pancreatic, or neurologic disorders.

7. Allergy to whey or herbal ingredients.

8. Participants who have any other disease or condition, or are using any medication, that in the judgment of the investigator would put them at unacceptable risk for participation in the study or may interfere with evaluations in the study or noncompliance with treatment or visits.

9. Participants who have been part of a clinical trial within 90 days prior to the screening.

10. Participants who have used whey or other supplemental proteins anytime in last 3 months

Related Conditions & MeSH terms

• Muscle Strength

Intervention

Other:
• Placebo without Exercise
2 Capsules to be taken 30 minutes before breakfast.
• Placebo with Exercise
2 Capsules to be taken 30 minutes before breakfast.
• IP I
2 Capsules to be taken 30 minutes before breakfast.
• IP II
2 Capsules to be taken 30 minutes before breakfast.
• IP III
2 Capsules to be taken 30 minutes before breakfast.

Locations

Country	Name	City	State
India	Vedic Lifesciences	Mumbai	Maharashtra

Sponsors (1)

Lead Sponsor	Collaborator
Vedic Lifesciences Pvt. Ltd.

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	1-Repetition Maximum	The final weight lifted successfully for atleast 1 repetition but could not complete 3 repetition will be recorded as 1- RM.; Change in muscle strength as indicated by increase in 1Repetition Maximum leg press weight	Day 0 to Day 28 and /or day56
Secondary	Body fat composition: Lean Muscle Mass by Dual-energy X-ray absorptiometry	Increase in lean muscle mass by DXA	Day 0 to Day 28 and /or day56
Secondary	Quality of Sleep: Modified Insomnia Severity Index	Improvement in sleep quality as assessed by the modified Insomnia Severity Index	Day 0 to Day 28 and /or day56
Secondary	Visual Analogue Scale for Fatigue	Reduction in fatigue level as assessed by the 11-point Visual Analogue scale for Fatigue	Day 0 to Day 28 and /or day56
Secondary	Mid-thigh Girth	Increase in mid-thigh muscle-girth (prior to exercise) at midpoint between inguinal fold and superior border of patella.	Day 0 to Day 28 and /or day56
Secondary	Digestive diary	Participants will be asked to fill out a paper/online digestive diary to monitor any significant changes that might occur to the digestive system due to the consumption of WPI and the IP.; there should be No significant effect on digestive system as per participant digestive diary.	Day 0 to Day 28 and /or day56